Patients n | 11 | 7 | | 18 |
Baseline characteristics | | | | |
Males | 9 (81.8) | 7 (100) | 0.49 | 16 (88.9) |
Caucasians | 10 (90.9) | 7 (100) | 1 | 17 (94.4) |
Current or ex-smoker | 5 (45.4) | 4 (57.1) | 1 | 9 (50) |
Room air Pa,O2 mmHg | 75 (68–84) | 74# | | 74.5 (68–84) |
FVC % pred | 75 (70–78) | 66 (57–78) | 0.54 | 70 (62–78) |
DL,CO % pred | 40.5 (36–46.5) | 46 (38–49) | 0.57 | 42 (38–47) |
6MWD m | 415 (350–420) | 422.5 (380–457.5) | 0.37 | 415 (350–425) |
Characteristics at time of exacerbation | | | | |
Age yrs | 67 (65–72) | 67 (58–73) | 0.93 | 67 (65–72) |
BMI kg·m−2 | 28.8 (27.7–31.7) | 26.4 (24.2–29) | 0.22 | 27.9 (25.6–30.6) |
Time from onset of symptoms to admission days | 7 (3–18) | 47 (39–62) | 0.003 | 18.5 (6–44) |
Proportion of new opacities on HRCT that were multifocal or diffuse | 6/9 (66.7) | 2/5 (40) | 0.58 | 8/14 (57.1) |
Room air Pa,O2 mmHg | 53.5 (47–59.5) | 60 (54–66) | 0.33 | 55 (51–68) |
Pa,O2/FI,O2 | 255 (224–283) | 286 (257–314) | 0.33 | 262 (243–324) |
FVC % pred | 57 (51–61) | 56 (50–65) | 0.81 | 57 (50–64) |
DL,CO % pred | 25 (19–34) | 24 (22–37) | 0.90 | 24 (22–34) |